Treatment with pergolide or cyproheptadine of pituitary pars intermedia dysfunction (equine Cushing's disease)

Journal of Veterinary Internal Medicine

Volumn 16, Issue 6, 2002, Pages 742-746

  Donaldson, Mark T ^a,b   LaMonte, Bernadette H ^a   Morresey, Peter ^a   Smith, Gary ^a   Beech, Jill ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

ACTH; Hyperadrenocorticism; Pituitary adenoma; Pituitary dysfunction; Pituitary hyperplasia; Pituitary tumor

Indexed keywords

ANTIDIABETIC AGENT; CORTICOTROPIN; CYPROHEPTADINE; DOPAMINE RECEPTOR STIMULATING AGENT; INSULIN; PERGOLIDE; SEROTONIN ANTAGONIST;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CLINICAL TRIAL; CUSHING SYNDROME; FEMALE; GLUCOSE BLOOD LEVEL; HORSE; HORSE DISEASE; MALE; PATHOLOGY; TREATMENT OUTCOME;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; BLOOD GLUCOSE; CUSHING SYNDROME; CYPROHEPTADINE; DOPAMINE AGONISTS; FEMALE; HORSE DISEASES; HORSES; HYPOGLYCEMIC AGENTS; INSULIN; MALE; PERGOLIDE; SEROTONIN ANTAGONISTS; TREATMENT OUTCOME;

EID: 0036835141     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2002.tb02418.x     Document Type: Article

References (23)

1. Millington WR, Dybdal NO, Dawson R, Jr., et al. Equine Cushing's disease: Differential regulation of beta-endorphin processing in tumors of the intermediate pituitary. Endocrinology 1988;123:1598-1604.
2. Orth DN, Holscher MA, Wilson MG, et al. Equine Cushing's disease: Plasma immunoreactive proopiolipomelanocortin peptide and cortisol levels basally and in response to diagnostic tests. Endocrinology 1982;110:1430-1441.
3. Couetil L, Paradis MR, Knoll J. Plasma adrenocorticotropin concentration in healthy horses and in hoises with clinical signs of hyperadrenocorticism. J Vet Intern Med 1996;10:1-6
4. Beech J. Diseases of the pituitary gland In: Colahan PT, Mayhew IG, Merritt AM, eds. Equine Medicine and Surgery, 5th ed. St. Louis, MO: Mosby; 1999:1951-1956.
5. Dybdal NO, Hargreaves KM, Madigan JE, et al. Diagnostic testing for pituitary pars intermedia dysfunction in horses. J Am Vet Med Assoc 1994;204:627-632.
6. van der Kolk JH, Wensing T, Kalsbeek HC, et al. Laboratory diagnosis of equine pituitary pars intermedia adenoma. Domest Anim Endocrinol 1995;12:35-39.
7. Schott CL, Coursen CL, Eberhart SW, et al. The Michigan Cushing's Project. Proc Am Assoc Equine Pract 2001:22-24.
8. Perkins G, Lamb S, Erb H, et al. Plasma adrenocorticotropin (ACTH) concentrations and clinical response in horses treated for equine Cushing's disease with cyproheptadine or pergolide. Equine Vet J 2002. In press.
9. Couetil L. Clinical response and plasma adrenocorticotropin concentration in horses with equine Cushing's disease treated with cyproheptadine. Proc Am Assoc Equine Pract 1996:297-298.
10. Garcia MC, Beech J. Equine intravenous glucose tolerance test: Glucose and insulin responses of healthy horses fed grain or hay and of horses with pituitary adenoma. Am J Vet Res 1986;47:570-572.
11. van der Kolk JH. Diseases of the pituitary gland including hyperadrenocorticism. In: Watson TD, ed. Metabolic and Endocrine Problems of the Horse. New York, NY: WB Saunders; 1998:41-59.
12. Levy M, Sojka J, Dybdal NO, et al. Diagnosis and treatment of equine Cushing's disease. Comp Cont Ed Vet 1999;21:766-769.
13. Dybdal NO. Pituitary pars intermedia dysfunction (equine Cushing's-like disease). In: Robinson NE, ed. Current Therapy in Equine Medicine. 4th ed. Philadelphia, PA: WB Saunders; 1997:499-501.
14. Peters D, Erfle J, Slobojan G. Low dose pergolide mesylate treatment for equine hypophyseal adenomas (Cushing's sydrome). Proc Am Assoc Equine Pract 1995:154-155.
15. Beech J. Diseases of the endocrine system. In: Colahan PT, Mayhew IG, Merritt AM, eds. Equine Medicine and Surgery, 4th ed. Goleta, CA: American Veterinary Publications; 1991:1737-1751.
16. Watson JL, Dybdal NO, Herrgesell EJ, et al. Equine Cushing's disease and the long-term treatment with oral pergolide mesylate. J Vet Intern Med 1998;12:220 (abstract).
17. Reimers TJ, Cowan RG, McCann JP, et al. Validation of a rapid solid-phase radioimmunoassay for canine, bovine, and equine insulin. Am J Vet Res 1982;43.1274-1278.
18. Evans JW, Thompson PG, Winget CM. Glucose and insulin biorhythms in the horse. J S Afr Vet Assoc 1974;45:317-329.
19. Freestone JF, Shoemaker K, Bessin R, et al. Insulin and glucose response following oral glucose administration in well-conditioned ponies. Equine Vet J Suppl 1992:13-17
20. Johnson PJ, Ganjam VK. Laminitis, "Hypothyroidism," and obesity: A peripheral cushingoid syndrome in horses? Proc Am Coll Vet Intern Med 1999:192-199.
21. Riggs WL Diabetes mellitus secondary to chronic necrotizing pancreatitis in a pony. Southwest Vet 1972;25:149-152.
22. Jeffrey JR. Diabetes mellitus secondary to chronic pancreatitis in a pony. J Am Vet Med Assoc 1968;153:1168-1175
23. Feldman EC. Hyperadrenocorticism (Cushing's syndrome) In: Feldman NC, Nelson R, eds Canine and Feline Endocrinology and Reproduction. Philadelphia, PA: WB Saunders; 1987:187-265.